Cardiovascular risk benefits of EPA and DHA supplements

Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials AbuMweis¬†et al., JHND Early View Background Over 200 clinical trials have examined the effect of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) supplements on risk factors associated with cardiovascular disease. However, an updated analysis … Continue reading Cardiovascular risk benefits of EPA and DHA supplements

Advertisements